Terms: = Lymphoma AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Prognosis
36 results:
1. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract] [Full Text] [Related]
2. The impact of MYD88 and pim1 in mature large B-cell non-Hodgkin lymphomas: Defining element of their evolution and prognosis.
Cristian M; Așchie M; Mitroi AF; Deacu M; Boșoteanu M; Bălțătescu GI; Stoica AG; Nicolau AA; Enciu M; Crețu AM; Caloian AD; Orășanu CI; Poinăreanu I
Medicine (Baltimore); 2024 Feb; 103(6):e36269. PubMed ID: 38335426
[TBL] [Abstract] [Full Text] [Related]
3. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of genomic alterations in primary central nervous system lymphoma.
He X; Fan X; Shan Y; Ji X; Su L; Wang Y
Medicine (Baltimore); 2023 Sep; 102(35):e34931. PubMed ID: 37657032
[TBL] [Abstract] [Full Text] [Related]
5. IGH 3'RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IGH rearrangement in unmutated chronic lymphocytic leukemia.
Al Jamal I; Parquet M; Guiyedi K; Aoufouchi S; Le Guillou M; Rizzo D; Pollet J; Dupont M; Boulin M; Faumont N; Boutouil H; Jardin F; Ruminy P; El Hamel C; Lerat J; Al Hamaoui S; Makdissy N; Feuillard J; Gachard N; Peron S
Haematologica; 2024 Feb; 109(2):466-478. PubMed ID: 37496419
[TBL] [Abstract] [Full Text] [Related]
6. Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas.
Kaulen LD; Denisova E; Hinz F; Hai L; Friedel D; Henegariu O; Hoffmann DC; Ito J; Kourtesakis A; Lehnert P; Doubrovinskaia S; Karschnia P; von Baumgarten L; Kessler T; Baehring JM; Brors B; Sahm F; Wick W
Acta Neuropathol; 2023 Sep; 146(3):499-514. PubMed ID: 37495858
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathologic characteristics and prognostic analysis of testicular diffuse large B-cell lymphoma].
Wang Y; Shi ZY; Shi Q; Wang S; Zhang MC; Shen R; He Y; Qiu HL; Yi HM; Dong L; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):321-327. PubMed ID: 37357002
[No Abstract] [Full Text] [Related]
8. Activation-induced cytidine deaminase displays an alternative co-factor for modulating pim1 expression in diffuse large B cell lymphoma cell lines.
Wang Y; Miao Y; Zhou W; Bi Y; Ji Y; Ma Y
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):1-7. PubMed ID: 37300695
[TBL] [Abstract] [Full Text] [Related]
9. MYD88
Qin Y; Qiu T; Xie Z; Chen X; Liu P; Yang J; He X; Gui L; Zhou S; Jiang H; Zhang C; Yang S; Tang L; Shi Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8483-8494. PubMed ID: 37093346
[TBL] [Abstract] [Full Text] [Related]
10. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
11. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical characteristics and prognosis of primary and secondary diffuse large B-cell lymphoma of the pancreas].
Huo YJ; Zhang MC; Shi Q; Qin W; Shi ZY; Wang L; Cheng S; Xu PP; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):55-61. PubMed ID: 36987724
[No Abstract] [Full Text] [Related]
13. Role and mechanism of pim family in the immune microenvironment of diffuse large B cell lymphoma.
Wang C; Chen Q; Luo H; Chen R
World J Surg Oncol; 2023 Mar; 21(1):76. PubMed ID: 36871027
[TBL] [Abstract] [Full Text] [Related]
14. Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis.
Lv L; Qi X; Wang C; Ma Y; Nie Y; Abulaiti R; Zhang F; Shi Q; Kou Z; Abuduer M; Zhai S; An L; Huang Q; Gu Z; Ou Q; Liu H; Wang Z; Shao Y; Sun Z; Fu L; Wang X; Mao M; Li Y
Clin Exp Med; 2023 Oct; 23(6):2675-2685. PubMed ID: 36811800
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical features and prognosis of 166 cases of MYC/BCL2 double-expression diffuse large B-cell lymphoma].
Tang SH; Tian L; Zhao W; Wang J; Ke XY
Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):771-777. PubMed ID: 36709172
[No Abstract] [Full Text] [Related]
16. Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell lymphoma Patients.
Wang H; Lin Y; Li Z; Wu Y; Yang Z; Gao S; Lin F
Clin Lab; 2023 Jan; 69(1):. PubMed ID: 36649512
[TBL] [Abstract] [Full Text] [Related]
17. Clinical significance of MYD88 non-L265P mutations in diffuse large B-cell lymphoma.
Xie J; Shen X; Shi Q; Yi H; Ouyang B; Zhang Z; Gu Y; Dong L
Hematol Oncol; 2022 Dec; 40(5):885-893. PubMed ID: 36053490
[TBL] [Abstract] [Full Text] [Related]
18. Genomic Mutation Landscape of Primary Breast lymphoma: Next-Generation Sequencing Analysis.
Zhang W; Huang C; Liu J; Wu L; Zhang H; Wu X; Wang L; Li W; Liu W; Liu L
Dis Markers; 2022; 2022():6441139. PubMed ID: 35937947
[TBL] [Abstract] [Full Text] [Related]
19. Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell lymphoma.
Zhu Y; Fu D; Shi Q; Shi Z; Dong L; Yi H; Liu Z; Feng Y; Liu Q; Fang H; Cheng S; Wang L; Tian Q; Xu P; Zhao W
Front Immunol; 2022; 13():842439. PubMed ID: 35401516
[TBL] [Abstract] [Full Text] [Related]
20. SGK1 mutation status can further stratify patients with germinal center B-cell-like diffuse large B-cell lymphoma into different prognostic subgroups.
Guo B; Huang Y; Duan Y; Liao C; Cen H
Cancer Med; 2022 Mar; 11(5):1281-1291. PubMed ID: 35106936
[TBL] [Abstract] [Full Text] [Related]
[Next]
